Home › NDC Lookup › RxCUI directory › RxCUI 1719003

Gemcitabine 1000 MG Injection — RxCUI 1719003

RxNorm drug concept · Semantic clinical drug
RxCUI 1719003 Semantic clinical drug · SCD ● Current RxNorm concept 19 FDA products 20 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1719003
Official nameGemcitabine 1000 MG Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asgemcitabine 1 GM Injection; gemcitabine (as gemcitamine HCl) 1 GM Injection
FDA products mapped19
Package NDCs mapped20
Reported Medicaid activity (SDUD)2,834 prescriptions · 20 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Gemcitabine Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Gemcitabine is used to treat four types of cancer: advanced ovarian cancer that has come back after platinum-based chemo, metastatic breast cancer (combined with paclitaxel), non-s...
  • You'll receive gemcitabine through an IV (into a vein) at a clinic or infusion center — it's not a pill you take at home. Each infusion takes about 30 minutes, and it's typically g...
  • How is gemcitabine given, and what should I expect during infusion?
  • The most common side effects include nausea, vomiting, fatigue from low red blood cells, fever, rash, and swelling. Your blood counts will often drop during treatment, which is exp...
📖 Read our full Gemcitabine Injection guide →

🕸️ Concept Web — How Gemcitabine 1000 MG Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Gemcitabine 1000 MG Injection RxCUI 1719003

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Gemcitabine 12574
  2. Dose forms 4

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Gemcitabine Injection 1718999
    • Gemcitabine Injectable Product 1156710
    • Injection 1649574
    • Injectable Product 1151126
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Gemcitabine 1000 MG 1719002

Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Gemcitabine 1000 MG SCDC · 1719002
  • Gemcitabine Injection SCDF · 1718999
  • Gemcitabine Injectable Product SCDG · 1156710

📦 FDA Products & Package NDCs

19 products · 20 package NDCs
20 package NDCs map to RxCUI 1719003 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00409-0185-01 1 VIAL, SINGLE-DOSE in 1 CARTON (0409-0185-01) / 5 mL in 1... Gemcitabine Hospira, Inc. 2011-07-26
00409-0186-01 1 VIAL, SINGLE-DOSE in 1 CARTON (0409-0186-01) / 25 mL in 1... Gemcitabine Hospira, Inc. 2011-07-26
16714-0909-01 1 VIAL, SINGLE-DOSE in 1 CARTON (16714-909-01) / 1 INJECTIO... GEMCITABINE NorthStar Rx LLC 2018-11-01
16714-0930-01 1 VIAL, SINGLE-DOSE in 1 CARTON (16714-930-01) / 1 INJECTIO... GEMCITABINE NorthStar Rx LLC 2018-11-01
25021-0234-10 1 VIAL in 1 CARTON (25021-234-10) / 5 mL in 1 VIAL gemcitabine Sagent Pharmaceuticals 2014-12-29
25021-0235-50 1 VIAL in 1 CARTON (25021-235-50) / 25 mL in 1 VIAL gemcitabine Sagent Pharmaceuticals 2014-12-29
25021-0235-51 10 VIAL in 1 CARTON (25021-235-51) / 25 mL in 1 VIAL gemcitabine Sagent Pharmaceuticals 2022-12-15
55111-0686-07 1 VIAL, SINGLE-USE in 1 CARTON (55111-686-07) / 5 mL in 1 V... gemcitabine Dr. Reddy's Laboratories Limited 2011-07-25
55111-0687-25 1 VIAL, SINGLE-USE in 1 CARTON (55111-687-25) / 25 mL in 1... gemcitabine Dr. Reddy's Laboratories Limited 2011-07-25
63323-0102-13 1 VIAL, SINGLE-DOSE in 1 BOX (63323-102-13) / 5 mL in 1 VIA... GEMCITABINE Fresenius Kabi USA, LLC 2011-07-26
63323-0102-94 1 VIAL, SINGLE-DOSE in 1 BOX (63323-102-94) / 5 mL in 1 VIA... GEMCITABINE Fresenius Kabi USA, LLC 2011-07-26
63323-0125-53 1 VIAL, SINGLE-DOSE in 1 BOX (63323-125-53) / 25 mL in 1 VI... GEMCITABINE Fresenius Kabi USA, LLC 2011-07-26
63323-0125-94 1 VIAL, SINGLE-DOSE in 1 BOX (63323-125-94) / 25 mL in 1 VI... GEMCITABINE Fresenius Kabi USA, LLC 2011-07-26
63323-0126-03 1 VIAL, SINGLE-DOSE in 1 BOX (63323-126-03) / 50 mL in 1 VI... GEMCITABINE Fresenius Kabi USA, LLC 2011-07-26
68083-0148-01 1 VIAL in 1 CARTON (68083-148-01) / 5 mL in 1 VIAL gemcitabine hydrochloride Gland Pharma Limited 2016-02-01
68083-0149-01 1 VIAL in 1 CARTON (68083-149-01) / 25 mL in 1 VIAL gemcitabine hydrochloride Gland Pharma Limited 2016-02-01
71288-0113-10 1 VIAL, SINGLE-DOSE in 1 CARTON (71288-113-10) / 1 INJECTIO... GEMCITABINE Meitheal Pharmaceuticals Inc. 2018-11-01
71288-0114-50 1 VIAL, SINGLE-DOSE in 1 CARTON (71288-114-50) / 1 INJECTIO... GEMCITABINE Meitheal Pharmaceuticals Inc. 2018-11-01
82511-0008-20 1 VIAL, SINGLE-USE in 1 CARTON (82511-008-20) / 5 mL in 1 V... Gemcitabine hydrochloride Teyro Labs Private Limited 2024-08-08
82511-0009-10 1 VIAL, SINGLE-USE in 1 CARTON (82511-009-10) / 25 mL in 1... Gemcitabine hydrochloride Teyro Labs Private Limited 2024-08-08
Observed labelers: Fresenius Kabi USA, LLC (5) · Sagent Pharmaceuticals (3) · Dr. Reddy's Laboratories Limited (2) · Gland Pharma Limited (2) · Hospira, Inc. (2) · Meitheal Pharmaceuticals Inc. (2) · +2 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J9201 In gemcitabine hcl nos 200mg 11 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.